Show simple item record

dc.creatorArias, Tomas D.
dc.creatorJorge, L. F.
dc.creatorBarrantes Mesén, Ramiro
dc.date.accessioned2016-01-15T17:19:43Z
dc.date.available2016-01-15T17:19:43Z
dc.date.issued1991
dc.identifier.citationhttp://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.1991.tb03870.x/abstractes_ES
dc.identifier.issn1365-2125
dc.identifier.urihttp://hdl.handle.net/10669/15491
dc.descriptioncarta al editor -- Universidad de Costa Rica. Instituto de Investigaciones en Salud. 1991es_ES
dc.description.abstractDefinitions of genetic polymorphism currently employed in the pharmacological literature have been incorrectly used (Kalow, 1984) and uncritically imported from population genetics [e.g., Weinshilboum (1984), Evans (1977)], apparently without regard to the problems their application might present in pharmacogenetics or, more specifically, in pharmacogenetic studies of populations.es_ES
dc.description.sponsorshipUniversidad de Costa Rica. Instituto de Investigaciones en Saludes_ES
dc.language.isoen_USes_ES
dc.sourceBritish Journal of Clinical Pharmacology 31:117-119es_ES
dc.subjectfarmacogenesises_ES
dc.subjectpolimorfismoes_ES
dc.subjectGenética humanaes_ES
dc.subjectGenéticaes_ES
dc.titleUses and misuses of definitions of genetic polymorphism: A perspective from population pharmacogeneticses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.typeArtículo científicoes_ES
dc.identifier.doi10.1111/j.1365-2125.1991.tb03870.x
dc.description.procedenceUCR::Vicerrectoría de Investigación::Unidades de Investigación::Ciencias de la Salud::Instituto de Investigaciones en Salud (INISA)es_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record